chrisvoncsefalvay/vaers-outcomes huggingface dataset:
It was reported that an adult patient was vaccinated with a first, second, and third dose of hepatitis B virus vaccine. Subsequently, after the third dose, the patient's liver function tests were elevated. This case has not been verified by a health care professional. The outcome of the event was unknown. Elevated liver function tests was considered an other important medical event (OMIC). This was originally reported by a consumer.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71-year-old female patient (not pregnant) received BNT162b2 (BNT162B2 NOS), on 14Oct2022 at 18:30 as dose number unknown, single (Lot number: GH6665) at the age of 70 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "known allergies: Sulpha" (unspecified if ongoing); "High blood pressure" (unspecified if ongoing); "Hashimotos Thyroiditis" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19 which included Paxlovid from 05Jan2023 to 09Jan2023.
passed out; felt weak; fell out; This spontaneous case was reported by a nurse and describes the occurrence of LOSS OF CONSCIOUSNESS (passed out), ASTHENIA (felt weak) and FALL (fell out) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (had covid last year) and Illness (having some illnesses).   On 05-Jan-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Jan-2022, the patient experienced LOSS OF CONSCIOUSNESS (passed out). 05-Jan-2022, the patient experienced ASTHENIA (felt weak) and FALL (fell out). At the time of the report, LOSS OF CONSCIOUSNESS (passed out), ASTHENIA (felt weak) and FALL (fell out) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Reporter daughter was 50 years old. She had been having some illnesses along the way and had covid last year, she could not tell she had it. She had the first dose of the Moderna COVID-19 vaccine and 6 hours later she passed out. She felt weak and fell out.  No Concomitant medications were reported.  No treatment medications were reported.  Company Comment: The only reported events in this case are non-serious, hence no CC is required.   Most recent FOLLOW-UP information incorporated above includes: On 05-Jan-2022: Follow up received contains no new information.; Sender's Comments: The only reported events in this case are non-serious, hence no CC is required.
"I" was very light headed; "I" had chills; "I" felt fatigued; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL 3248) via an unspecified route of administration in the left arm on 01Mar2021 at 14:30 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included lisinopril 10 mg (MANUFACTURER UNKNOWN) for unknown indication from unknown date and unknown if ongoing. On 02Mar2021 at 14:30, about 24 hours after the shot, the patient experienced very light headed and had chills. The patient felt fatigued as well. The events did not result in doctor or other healthcare professional office/clinic visit/emergency visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events very light headed, chills and felt fatigued were resolved on an unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Soarness of the left arm. Patient cannot lift arm over his head or place a gallon of  milk on the top shelf.
From 2 days after getting the Flu shot, (still happening) I have had general malaise, body aches, non-productive cough, slight headache, sore throat.
Syncope and collapse less then one minute after receiving immunizations. Patient was pale, nauseous, blood pressure 100/62. Patient laid supine for 1.5 hours in the office after onset of symptoms until she felt well enough to leave the office. 1 hour after immunization patient started complaining of severe right shoulder pain. On 6/23/16 patient called to report abdominal pain 4/10, chills, body aches and severe headache. Symptoms did not resolved till 06/24/16.
September 27, 2021  New nervous system reaction:  Over 20 years ago, I was diagnosed with RSD (Reflex Sympathetic Dystrophy) in my left knee.  I spent over 2 years rehabbing and have had no signs of this nervous system disease until Tuesday, September 21, 2021, about 1:15 pm.  While I was sitting at my desk working, sharp stabbing nerve pains in my left knee began to happen.  These pains were milder than my original episode over 20 years ago and only lasted until Sunday, September 26, 2021, 10:30 am.  This episode, happened quickly, like flipping a light switch on and ended quickly like, turning off a light.  At this time, Monday, September 27, 2021, there is no sign of this episode.  During those few days, of this episode, I reverted to treatments that I had done to help the RSD.  I was even able to work out normally this morning.   I have no idea if it has gone dormant again or if it will return any time soon, but I did feel it was necessary to add to my previous report (VAERS ID: 1675629 / E-Report Number:  636305).  Both of these incidents have been reported to my Primary Doctor  with no response.  I am definitely disappointed in the no response and terrified of another injection.  Thank you again for your time and I hope this information can be helpful for the future.
Headache, Sedation, Myalgia, Arthralgia, Fever, Diarrhea, Chills Narrative:
Patient did not disclose that they had any other COVID vaccine prior to this one. Patient disclosed dishonesty in disclosing they had received a Johnson and Johnson vaccination and was intentionally seeking the Moderna Vaccine.
For the past two weeks, I have had a headache, fever, chills, body aches and loss of appetite. I am starting to feel much better now. I don't have a fever or chills anymore. I was not prescribed any medications because it is so hard to get into the doctor's office where I live. I haven't even taken any over-the-counter medications. I just try to get over things on my own.
Received last COVID vaccine 05/31/2021 No Booster dose   To the ER on 11/24/2021 after exposure from son with symptoms of diarrhea x2 days and Temp MAX 100.3, nasal congestion.   Patient is 14 weeks pregnant.
Information has been received from a physician concerning a 6 year old male who "at 15 months old" (in approximately August 2005), was vaccinated with the first dose of VARIVAX (Merck) (LOT# 647960/0070R) and the second dose (LOT# 658935/1349U) "at age 4" (in approximately May 2008). On approximately 20-SEP-2010 the patient experienced scattered rash on his trunk and extremities. The physician stated that the patient developed a scattered rash on his trunk and extremities after receiving VARIVAX (Merck). On 20-SEP-2010, patient was seen by the physician for the symptom. No specific dates were provided for administration of the doses. No further AE information provided. Follow up information was received from a nurse who reported that the 6 year old male student on 22-MAY-2008 was vaccinated subcutaneously into the right thigh with a second dose of VARIVAX (Merck) (LOT# 658935/1349U). There was no illness at the time of the vaccination. On 20-SEP-2010 the school nurse called the patient's guardian to come to get the patient at school. The patient was broke out in a rash and not feeling well at 14:15. The patient was brought straight to the physician's office. No relevant laboratory data was reported. The patient didn't go to school for 1 week. On an unspecified date, the patient recovered. No further information is available.
Patient experienced light headedness and we laid her down immediately after the SHINGRIX vaccine. She sat back up and felt ok and then laid back down. After her mom got her vaccine she was feeling better and able to walk around and leave safely. She reported not eating breakfast and she also received her booster dose of pfizer. She never lost consciousness. Vaers/scrt will be reported after this note.
Patient had an allergic reaction-hives all over the body, itching, rash. Went to ER twice 9/30/16 and 10/2/16. Got oral prednisone, diphenhydramine and famotidine.
Symptoms started the night of the vaccination:  very, very sore arm; felt feverish; weak; body aches; stuffy head; runny nose; watery eyes; dehydrated; very thirsty; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 74-year-old female patient (not pregnant) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 29Sep2023 at 13:30 as dose 4, (booster), single (Lot number: HD9835) at the age of 74 years, in right arm for covid-19 immunisation; influenza vaccine (INFLUENZA VACCINE), on 29Sep2023 as dose 1, single (Batch/Lot number: unknown), in left arm for immunisation. The patient's relevant medical history included: "HTN" (unspecified if ongoing); "Bipolar disorder" (unspecified if ongoing); "Sulfa allergy" (unspecified if ongoing); "Penicillins allergy" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 3 (BOOSTER), SINGLE;  MANUFACTURER UNKNOWN), for Covid-19 immunization; Covid-19 vaccine (DOSE 2, SINGLE;  MANUFACTURER UNKNOWN), for Covid-19 immunization; Covid-19 vaccine (DOSE 1, SINGLE;  MANUFACTURER UNKNOWN), for Covid-19 immunization. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 01Oct2023 at 12:00, outcome "recovering", described as "Symptoms started the night of the vaccination:  very, very sore arm"; PAIN (non-serious) with onset 01Oct2023 at 12:00, outcome "recovering", described as "body aches"; DEHYDRATION (non-serious) with onset 01Oct2023 at 12:00, outcome "recovering", described as "dehydrated"; PYREXIA (non-serious) with onset 01Oct2023 at 12:00, outcome "recovering", described as "felt feverish"; RHINORRHOEA (non-serious) with onset 01Oct2023 at 12:00, outcome "recovering", described as "runny nose"; UPPER RESPIRATORY TRACT CONGESTION (non-serious) with onset 01Oct2023 at 12:00, outcome "recovering", described as "stuffy head"; THIRST (non-serious) with onset 01Oct2023 at 12:00, outcome "recovering", described as "very thirsty"; LACRIMATION INCREASED (non-serious) with onset 01Oct2023 at 12:00, outcome "recovering", described as "watery eyes"; ASTHENIA (non-serious) with onset 01Oct2023 at 12:00, outcome "recovering", described as "weak". Therapeutic measures were taken as a result of pain in extremity, pyrexia, asthenia, pain, upper respiratory tract congestion, rhinorrhoea, lacrimation increased, dehydration, thirst.  Additional information: Symptoms started the night of the vaccination: very, very sore arm, felt feverish & weak, body aches, stuffy head, runny nose, watery eyes, dehydrated & very thirsty. Patient had no other vaccine in four weeks, did not have covid prior to vaccination and did not test for covid post vaccination.
blotchy now going down to her wrist; Arm was warm at injection site; Circled her arm above elbow going down; hard at the injection site; Arm was itchy at injection site; arm was red at  injection site; arm hurt at injection site; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (blotchy now going down to her wrist), VACCINATION SITE WARMTH (Arm was warm at injection site), VACCINATION SITE REACTION (Circled her arm above elbow going down), VACCINATION SITE INDURATION (hard at the injection site) and VACCINATION SITE PRURITUS (Arm was itchy at injection site) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included METFORMIN, ATORVASTATIN CALCIUM (LIPITOR) and ATORVASTATIN for an unknown indication.   On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced VACCINATION SITE PAIN (arm hurt at injection site). On 07-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Arm was warm at injection site), VACCINATION SITE REACTION (Circled her arm above elbow going down), VACCINATION SITE INDURATION (hard at the injection site), VACCINATION SITE PRURITUS (Arm was itchy at injection site) and VACCINATION SITE ERYTHEMA (arm was red at  injection site). On 22-Mar-2021, the patient experienced RASH MACULAR (blotchy now going down to her wrist). At the time of the report, RASH MACULAR (blotchy now going down to her wrist), VACCINATION SITE WARMTH (Arm was warm at injection site), VACCINATION SITE REACTION (Circled her arm above elbow going down), VACCINATION SITE INDURATION (hard at the injection site), VACCINATION SITE PRURITUS (Arm was itchy at injection site), VACCINATION SITE PAIN (arm hurt at injection site) and VACCINATION SITE ERYTHEMA (arm was red at  injection site) had resolved.            Concomitant product also included Iron supplement.  No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 09-May-2021: Event outcome updated
Since May 1st I have experienced muscle stiffness, cramps, increased arthritic pain in all joints of the body.  I have had body freeze up , headaches.  The most significant issue is my A1C going for a 5.8 to a 11.4!!!!  3 months of 1,000 mg of metphormin A1C dropped to 9.1, they the added Rybelsus 3mg for 30 days and 2 months of 7mg.  I have had nothing but fatigue and tiredness.  10hrs sleep plus naps on my day off.  having a hard time working out not having the energy
Skin has pain, similar to bee stings; Rash on her wrists and inside her legs / Rash appeared purple-like in color. The rash also itched; purple-like in color; rash; This case was reported by a consumer and described the occurrence of skin pain in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   In November 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced skin pain, itchy rash, skin discoloration and rash. The patient was treated with antivirals nos (Antiviral (Drug Name Unknown)). On an unknown date, the outcome of the skin pain, itchy rash, skin discoloration and rash were unknown.   It was unknown if the reporter considered the skin pain, itchy rash, skin discoloration and rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient reported that she received dose 1 and after an unspecified period of time, she developed a rash on her wrists and inside her legs. The rash appeared purple-like in color. The rash also itched. The patient also noted that her skin has pain, similar to bee stings in the affected rash areas. The patient got some alleviation of symptoms by using antiviral medications, not specified. The reporter consented to follow up.
Acute headache radiating to neck and right shoulder and right eye. Acute hypertension with hypertensive crisis BP 223/113 needing Emergency department admission.   Following this ED visit the the BP had been uncontrolled  with ongoing headaches and right sided neck pain radiating to the right eye/head through March and in April have improved.   During this time had #2 Pfizer vaccine  2/12/21 and had experienced  arm pain and headache as well as a spike in her BPs as well as right sided neck pain radiating to her  right eye
Tinnitus, mostly white noise but sometimes ringing; she had flu feeling for one day after the second dose .; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Tinnitus, mostly white noise but sometimes ringing) and INFLUENZA LIKE ILLNESS (she had flu feeling for one day after the second dose .) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028A21A and 023M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced TINNITUS (Tinnitus, mostly white noise but sometimes ringing) and INFLUENZA LIKE ILLNESS (she had flu feeling for one day after the second dose .). At the time of the report, TINNITUS (Tinnitus, mostly white noise but sometimes ringing) and INFLUENZA LIKE ILLNESS (she had flu feeling for one day after the second dose .) outcome was unknown.            No concomitant medication reported. No treatment information was provided.   This case was linked to MOD-2021-288321 (Patient Link).   Reporter did not allow further contact
It was reported that a pt (3 of 10) received a TD Adult that was inadvertently administered intradermal. The pt developed a large local red, hard area at the injection site. Further information is being requested.
Initial misuse report received from a healthcare professional on 06 AUGUST 2013. An 01-year-old patient received a dose of ADACEL in error. The patient had previously received three doses of DTap on unspecified dates. No adverse event was reported. Documents held by sender: none.
Beginning of November, Started with palpitations, tachycardia, fatigue, weight loss- diagnosis likely thyroiditis.
Received shot Sunday evening, sore arm as expected thru Monday. Tuesday evening, blood pressure spiked became angry and exhausted and had to lie down. Reported to Dr on Wednesday morning that left arm crease near elbow painful and pulsating with heavy beats and not feeling too great. No where open to monitor BP bc of COVID-19, dr advised purchasing  BP monitor or going to ED of hospital for BP check.
Choking and difficulty breathing, around 4:00 PM.  Was able to breathe normally within a few minutes of the choking episode.  I developed a sore throat at that time.  Eyes then began to burn and weep.  They were inflamed, and had a white mucoid discharge.  At bedtime (10:00 PM) I experienced chills.  My eyes remained inflamed the following morning, but were back to normal by afternoon.  The sore throat was gone by morning.
WITHIN 8 HOURS I EXPERIENCED CHILLS, FEVER, JOINT PAIN  AND A TERRIBLE HEADACHE.THESE SYMPTOMS LASTED FOR 24 HOURS.I WAS TOO ILL TO GET OUT OF BED AND FIND THE TYLENOL BOTTLE!
On day 3 if first  shot,  2/24/2021. I had intense pain in left arm pit  across collarbone,  to right armpit  when I lifted my arms,  described  best as a quick  shooting pain ending in a pinched nerve type feeling, lasting  a split  second.  Lasted for 7 days,but lingered on my right armpit, sore to touch.  On 2nd dose I waited 30 minutes  after just to be cautious.   Started driving  the 70 miles home and within  10 mi minutes  the same strange shooting  pain started  targeting  my , both  inside elbows, both wrist, rib cage.   Not as strong  a pain as first dose but very noticeable  .  This has continued, especially  when I exert myself.  At random times, random places on my body.  I did text my doctor  office.  The nurse practioner  said since it's a new virus,a new shot,she had not heard of this reaction and had no idea what to do except  for me to take tylenol.   I am getting  concerned  cause now  at random  times, I feel this Strang quick  shooting  pain from the back of my eyeball toward the front.  Only  lasts a split second, very annoying, but wondering  why it's still continuing  and showing up all over in random body areas etc.
Felt off, about one hour after receiving vaccine. Cognitive fatigue, seven hours after vaccination. Body discomfort/muscle aches 3:30am next day. On waking at 8:00am, physical and mental fatigue, full-body ache, sore arm, more difficult to lift, at injection site. Felt very much like having flu.
70 individuals received vaccine after 30 days window; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (70 individuals received vaccine after 30 days window) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (70 individuals received vaccine after 30 days window). At the time of the report, EXPIRED PRODUCT ADMINISTERED (70 individuals received vaccine after 30 days window) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter did not allow further contact  No concomitant medications were reported. No treatment related information has been reported.; Sender's Comments: This report refers to a case of Expired Product Administered for mRNA-1273 (Lot #: 029L20A)  with no associated AEs.
received Moderna Booster on 11/11 and on 11/12 started to develop a rash, over about a week it worsened becoming itchy, it was still present when he stopped by the health department on 11/24,  It is not worsening,.   He is using some topical hydrocortisone and will try benedryl at night as that is when it itches the most, he does have a history of psorias and will consult with his physican.
cellulitis left arm; rashes; not severe pain; This case was reported by a pharmacist via other manufacturer and described the occurrence of cellulitis in a 50-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included multiple myeloma. Concomitant products included ciprofloxacin and cetirizine (Zytrec).   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix and an unknown time after starting ciprofloxacin, the patient experienced cellulitis (serious criteria GSK medically significant), rash and pain. On an unknown date, the outcome of the cellulitis was not recovered/not resolved and the outcome of the rash and pain were unknown.   It was unknown if the reporter considered the cellulitis, rash and pain to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The patient had cellulitis left arm and might be a reaction to the vaccine. The patient also stated that he had common to get rashes but not with severe pain. The reporter stated that patient was not hospitalized due to the event cellulitis and no other seriousness criteria was reported. The lab data, corrective treatment if any was not provided. The permission to follow up denied.